Übersichtsarbeit
The Pharmacotherapy of Alzheimer's Disease Based on the Cholinergic Hypothesis: an Update
Neurodegeneration · 1995
DOI: 10.1006/neur.1995.0042 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurodegeneration, 1995. Verfasst von M Weinstock. Beteiligte Einrichtung: Department of Pharmacology, Hebrew University Hadassah Medical Centre, Jerusalem, Israel. Die Arbeit wurde bisher 87-mal zitiert (Crossref).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Alzheimer DiseaseCholinergic AgonistsCholinesterase InhibitorsHumansNerve DegenerationNerve Growth FactorsSynaptic Transmission
Substanzen
Cholinergic AgonistsCholinesterase InhibitorsNerve Growth Factors
Autor:innen und Institutionen
- Department of Pharmacology, Hebrew University Hadassah Medical Centre, Jerusalem, Israel.
Zitieren
APA
Weinstock, M. (1995). The Pharmacotherapy of Alzheimer's Disease Based on the Cholinergic Hypothesis: an Update. Neurodegeneration. https://doi.org/10.1006/neur.1995.0042
Vancouver
Weinstock M. The Pharmacotherapy of Alzheimer's Disease Based on the Cholinergic Hypothesis: an Update. Neurodegeneration. 1995. doi:10.1006/neur.1995.0042
BibTeX
@article{Weinstock1995,
author = {Weinstock, M},
title = {The Pharmacotherapy of Alzheimer's Disease Based on the Cholinergic Hypothesis: an Update},
journal = {Neurodegeneration},
year = {1995},
doi = {10.1006/neur.1995.0042}
}
EUVIMED